Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt

A research institution of the Federal Republic of Germany and the Free State of Bavaria. HMGU mission is to establish how environmental factors, lifestyle and individual genetic disposition interact in the development of diseases MGU deciphers previously unknown connections between genetics, lifestyle, and the environment

With excellent basic research and the highest level of scientific and technical infrastructure, develops innovative approaches for personalized diagnosis, therapy, and prevention. HMGU will contribute to the overall BOW project goals with the expertise acquired in a long history in the field of (nano)-particle toxicology with a proven track record and EU-funding. Specifically, HMGU will carry out the i) pre-screening characterization and in vitro nanotoxicology ii) In vivo characterization of BOW products in mice.

HMGU will contribute to the overall BOW project goals with the expertise acquired in a long history in the field of (nano)-particle toxicology with a proven track record and EU-funding. Specifically, HMGU will carry out the i) pre-screening characterization and in vitro nanotoxicology ii) In vivo characterization of BOW products in mice.

Comprehensive Molecular Analysis (CMA) and the partnering chair of analytical chemistry at University of Rostock (Rostock, Germany) jointly conduct research on adverse health effects of (nano)particles, fibers and aerosols.

The Institute of Lung Biology and Disease aims to achieve a mechanistic understanding of disease initiation and progression and aims to develop and harness novel therapeutic strategies, including nanotechnological approaches.

Team

Sebastiano Di Bucchianico

Group Leader | In vitro biological performance of evMBDs versus EVs and MBDs. WP4 leader.

Svenja Offer

PhD student | In vitro biological performance of evMBDs versus EVs and MBDs.

Jana Pantzke

PhD student | In vitro performance of evMBDs versus EVs and MBDs 

Markus Rehberg

Head on in vivo imaging | In vivo characterization of evMBDs versus EVs and MBDs.

Tobias Stöger

Group Leader | In vivo characterization of evMBDs versus EVs and MBDs.